BioPharma Resources

Drug Trial Radar · NCT06541704

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 975 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

975

Planned (sponsor's estimate)

Start

Oct 30, 2024

Primary completion

Jul 31, 2028

Study completion Apr 9, 2033

Sponsor

Lead sponsor
Regeneron PharmaceuticalsRegeneron (REGN)
Sponsor type
Industry
First posted
Aug 7, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atrophy (GA) caused by Age-related Macular Degeneration (AMD). Geographic atrophy is a medical term that refers to later-stage cases of AMD which is an eye condition affecting central vision (what one sees straight ahead). The purpose of this study is to evaluate the progression rate of Geographic Atrophy in eyes of patients treated with cemdisiran alone or in combination with pozelimab compared to those treated with placebo. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug(s) * How much study drug(s) are in the blood at different times * Whether the body makes antibodies against the study drug(s) (which could make the study drug(s) less effective or could lead to side effects)

Conditions

  • Age-related Macular Degeneration (AMD)
  • Geographic Atrophy (GA)

Interventions

  • PozelimabDrug

    Subcutaneous (SC) injection

  • CemdisiranDrug

    SC injection

  • PlaceboDrug

    SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Growth rate (slope) of total GA lesion area (mm^2 /year) from baseline, measured by Fundus Autofluorescence (FAF)Time frame: To week 52

Locations

233 sites in 11 countries. Site status is shown where the registry gives one.

  • Barnet Dulaney Perkins Eye Center-Ophthamalogy

    Chandler, Arizona · Recruiting

  • Barnet Dulaney Perkins Eye Center

    Phoenix, Arizona · Recruiting

  • Associated Retina Consultants

    Phoenix, Arizona · Recruiting

  • Retinal Research Institute

    Phoenix, Arizona · Recruiting

  • Retina Macula Institute of Arizona

    Scottsdale, Arizona · Recruiting

  • Retina Associates of Tuscan

    Tucson, Arizona · Recruiting

  • Retina Partners of Northwest Arkansas, PLLC

    Springdale, Arkansas · Recruiting

  • Retina Vitreous Associates Medical Group

    Beverly Hills, California · Recruiting

  • Retina Specialists of Beverly Hills- Department of Ophthalmology

    Beverly Hills, California · Recruiting

  • The Retina Partners

    Encino, California · Completed

  • Eye Medical Center of Fresno

    Fresno, California · Recruiting

  • Retina Consultants of Orange County

    Fullerton, California · Completed

  • Salehi Retina Institute dba Retina Associates of Southern California

    Huntington Beach, California · Recruiting

  • University of California Irvine

    Irvine, California · Recruiting

  • University of California San Diego, Jacobs Retina Center

    La Jolla, California · Recruiting

  • South Coast Retina Center

    Long Beach, California · Recruiting

  • American Institute of Research

    Los Angeles, California · Completed

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California · Recruiting

  • Jules Stein Eye Institute in David Geffen School of Medicine at UCLA

    Los Angeles, California · Recruiting

  • Retinal Consultants Medical Group Inc Modesto

    Modesto, California · Recruiting

  • Northern California Retina Vitreous Associates Medical Group, Inc.

    Mountain View, California · Recruiting

  • California Retina Consultants

    Oxnard, California · Recruiting

  • Desert Retina Consultants

    Palm Desert, California · Withdrawn

  • California Eye Specialists Medical Group Inc.

    Pasadena, California · Recruiting

  • Retina Consultants San Diego

    Poway, California · Recruiting

  • California Eye Specialists Medical Group, Inc.

    Redlands, California · Recruiting

  • Kaiser Permanente Riverside Medical Center

    Riverside, California · Recruiting

  • Optic Eye Care

    Rowland Heights, California · Recruiting

  • UC Davis Health Eye Center

    Sacramento, California · Recruiting

  • Vrmg Inc

    Sacramento, California · Recruiting

  • Retinal Consultants Medical Group (RCMG) - Greenback Lane Retina Center

    Sacramento, California · Recruiting

  • West Coast Retina Medical Group, Inc.

    San Francisco, California · Recruiting

  • Orange County Retina Medical Group

    Santa Ana, California · Recruiting

  • Macula Retina Vitreous Research Institute

    Torrance, California · Recruiting

  • University of Colorado

    Aurora, Colorado · Recruiting

  • Retina Consultants of Southern Colorado

    Colorado Springs, Colorado · Recruiting

  • Retina Specialists of Colorado - Denver

    Denver, Colorado · Recruiting

  • Southwest Retina Research Center

    Durango, Colorado · Recruiting

  • Colorado Retina - Lakewood

    Lakewood, Colorado · Recruiting

  • Eye care Center of Northern Colorado doing business as Advanced Vision Research Institute

    Longmont, Colorado · Recruiting

Showing 40 of 233 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.